Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACORAMIDIS vs ADAGRASIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACORAMIDIS vs ADAGRASIB: Safety Overview

Metric ACORAMIDIS ADAGRASIB
Total FAERS Reports 234 899
Deaths Reported 8 315
Death Rate 3.4% 35.0%
Hospitalizations 40 350
Average Patient Age 79.6 yrs 68.3 yrs
% Female Patients 18.3% 56.4%
FDA Approval Date Nov 22, 2024 Dec 12, 2022
Manufacturer BridgeBio Pharma, Inc. Mirati Therapeutics, Inc
Route ORAL ORAL
Marketing Status Prescription Prescription